In this article in the Journal of Health Politics, Policy and Law, KFF's Tricia Neuman, Jeannie Fuglesten Biniek and Juliette Cubanski examine three isssues facing Medicare’s future: privatization, affordability and spending/financing.

KFF | Healthcare Policy Issues

11.07.2025

States Expand Access to Ivermectin as Cancer Myths Continue, and Abortion Pill Faces False Water Supply Claim — The Monitor | KFF

This volume examines unsupported claims about ivermectin; the promotion of unproven “detox” supplements in response to falsehoods about the spike protein from the COVID-19 virus and vaccine; the unsubstantiated claim that byproducts from medication abortion pills contaminate the water supply; and the renewed debate over ADHD diagnoses and treatments.

KFF | Healthcare Policy Issues

15.07.2025

Demand for 988 Continues to Grow at Third Anniversary | KFF

This policy watch examines 988 on its third anniversary, drawing from the latest Lifeline data available through May 2025 and suicide death data from CDC WONDER for the period 2013 to 2023. 988 received 16.5 million contacts since its launch in July 2022, including 11.2 million calls, 2.9 million texts, and 2.4 million chats.

KFF | Healthcare Policy Issues

15.07.2025

Most Medicare Advantage Markets are Dominated by One or Two Insurers | KFF

Higher market concentration in Medicare Advantage insurance markets may lower the incentive for insurers to compete for potential enrollees by making plans more appealing through more comprehensive benefits or lower costs.

home›KFF | Healthcare Policy Issues

KFF | Healthcare Policy Issues

Health

Medicare at 60: A Popular Program Facing Challenges | KFF

States Expand Access to Ivermectin as Cancer Myths Continue, and Abortion Pill Faces False Water Supply Claim — The Monitor | KFF

Demand for 988 Continues to Grow at Third Anniversary | KFF

Most Medicare Advantage Markets are Dominated by One or Two Insurers | KFF

home
›
KFF | Healthcare Policy Issues